Back to search
Japanese Encephalitis Vaccine
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Japanese Encephalitis Vaccine trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Japanese Encephalitis Vaccine trials you may qualify forRACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
This is a 2-Stage, Phase I/II Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis mRNA Vaccines (GBP560) in Healthy Adult…
This is a phase IV, randomized, controlled, open-label study proceed in healthy children aged 8 months in China. The primary objective is to demonstrate the imm…
This is a single-arm, non-randomized, open-label post-marketing safety observation study. The purpose of this study is to investigate the safety of JEV-I given…
The main objective of this study is to evaluate the persistence of Japanese encephalitis antibodies in participants at the age of 6, after they have followed di…